Chronic pain in sickle cell disease (SCD) can begin in adolescence and impair quality of life (QOL) and functioning; however, very few studies have characterized chronic SCD-related pain in this age group. This study aimed to examine the sensory, inflammatory, and psychosocial characteristics of chronic pain in adolescents and young adults (AYA) with SCD and compare them according to the three ACTTION-APS Pain Taxonomy subtypes of chronic SCD pain.
Method
A cross-sectional comparative design of AYA ages 9–23 with chronic SCD pain and pain-free AYA with SCD was used. Quantitative sensory testing (QST) and psychosocial questionnaires were administered and analyzed using independent t-tests to detect differences between chronic pain and pain-free groups and analysis of variance was used to test differences between chronic pain subtypes. Salivary samples were collected for analysis of inflammatory markers IL-1β, 6, 8, 10, and TNF-α using standardized enzyme-linked immunosorbent assay kits.
Results
Nineteen chronic pain participants and four pain-free controls were enrolled. Participants with chronic SCD-related pain had a significantly higher pain burden, higher mechanical pain threshold, and lower warm detection threshold (WDT) compared with pain-free AYA with SCD. Statistical differences among the three chronic pain groups and the pain-free control group in psychosocial measures and WDT were also noted.
Discussion
The findings of this study can help nurses understand chronic pain in SCD youth. This study suggests that there are unique characteristics of chronic SCD-related pain in youth with varying disabilities and psychosocial needs; additional research is needed to explore these differences further.
AlboC.KumarS.PopeM.KidwellK. M.XuH.BowmanL.WellsL.BarrettN.FieldsS.BoraP.PatelN.KutlarA. (2020). Characteristics and potential biomarkers of adult sickle cell patients with chronic pain. European Journal of Haematology, 105(4), 419–425. https://doi.org/10.1111/ejh.13461
2.
AmeringerS.ElswickR. K.JrSmithW. (2014). Fatigue in adolescents and young adults with sickle cell disease: Biological and behavioral correlates and health-related quality of life. Journal of Pediatric Oncology Nursing, 31(1), 6–17. https://doi.org/10.1177/1043454213514632
3.
BadawyS. M.BarreraL.CaiS.ThompsonA. A. (2018). Association between participants’ characteristics, patient-reported outcomes, and clinical outcomes in youth with sickle cell disease. BioMed Research International, 2018, Article 8296139. https://doi.org/10.1155/2018/8296139
4.
BakshiN.LukomboI.ShnolH.BelferI.KrishnamurtiL. (2017). Psychological characteristics and pain frequency are associated with experimental pain sensitivity in pediatric patients with sickle cell disease. The Journal of Pain, 18(10), 1216–1228.
5.
BrandowA. M.CarrollC. P.CrearyS.Edwards-ElliottR.GlassbergJ.HurleyR. W.KutlarA.SeisaM.StinsonJ.StrouseJ. J.YusufF.ZempskyW.LangE. (2020). American Society of Hematology 2020 guidelines for sickle cell disease: Management of acute and chronic pain. Blood Advances, 4(12), 2656–2701. https://doi.org/10.1182/bloodadvances.2020001851
6.
BrandowA. M.DeBaunM. R. (2018). Key components of pain management for children and adults with sickle cell disease. Hematology/Oncology Clinics of North America, 32(3), 535–550. https://doi.org/10.1016/j.hoc.2018.01.014
7.
BrandowA. M.FarleyR. A.PanepintoJ. A. (2015). Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature. Pediatric Blood & Cancer, 62(9), 1501–1511. https://doi.org/10.1002/pbc.25574
8.
BrandowA. M.HansenK.NugentM.PanA.PanepintoJ. A.StuckyC. L. (2019). During acute painful events, children and adolescents with sickle cell disease have worse cold and mechanical hypersensitivity. Pain, 160(2), 407–416. https://doi.org/10.1097/j.pain.0000000000001407
9.
BrandowA. M.LiemR. I. (2022). Advances in the diagnosis and treatment of sickle cell disease. Journal of Hematology & Oncology, 15(1), Article 20. https://doi.org/10.1186/s13045-022-01237-z
10.
BrandowA. M.PanepintoJ. A. (2016). Clinical interpretation of quantitative sensory testing as a measure of pain sensitivity in patients with sickle cell disease. Journal of Pediatric Hematology/Oncology, 38(4), 288–293. https://doi.org/10.1097/MPH.0000000000000532
11.
BrandowA. M.WanderseeN. J.DasguptaM.HoffmannR. G.HilleryC. A.StuckyC. L.PanepintoJ. A. (2016). Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use. British Journal of Haematology, 175(2), 237–245. https://doi.org/10.1111/bjh.14300
CampbellC. M.Moscou-JacksonG.CarrollC. P.KileyK.HaywoodC.JrLanzkronS.HandM.EdwardsR. R.HaythornthwaiteJ. A. (2016). An evaluation of central sensitization in patients with sickle cell disease. The Journal of Pain, 17(5), 617–627. https://doi.org/10.1016/j.jpain.2016.01.475
14.
CarrollC. P.LanzkronS.JrHaywoodC.KileyK.PejsaM.Moscou-JacksonG.HaythornthwaiteJ. A.CampbellC. M.HaywoodC. J. (2016). Chronic opioid therapy and central sensitization in sickle cell disease. American Journal of Preventive Medicine, 51(1 Suppl 1), S69–S77. https://doi.org/10.1016/j.amepre.2016.02.012
15.
CarvalhoM. O. S.Araujo-SantosT.ReisJ. H. O.RochaL. C.CerqueiraB. A. V.LuzN. F.LyraI. M.LopesV. M.BarbosaC. G.FiuzaL. M.SantiagoR. P.FigueiredoC. V. B.da GuardaC. C.NetoM. B.BorgesV. M.GoncalvesM. S. (2018). Inflammatory mediators in sickle cell anaemia highlight the difference between steady state and crisis in paediatric patients. British Journal of Haematology, 182(6), 933–936. https://doi.org/10.1111/bjh.14896
16.
CunninghamN. R.Kashikar-ZuckS.MaraC.GoldschneiderK. R.RevickiD. A.DampierC.SherryD. D.CrosbyL.CarleA.CookK. F.MorganE. M. (2017). Development and validation of the self-reported PROMIS pediatric pain behavior item bank and short form scale. Pain, 158(7), 1323–1331. https://doi.org/10.1097/j.pain.0000000000000914
17.
DampierC.PalermoT. M.DarbariD. S.HassellK.SmithW.ZempskyW. (2017). AAPT diagnostic criteria for chronic sickle cell disease pain. The Journal of Pain, 18(5), 490–498. https://doi.org/10.1016/j.jpain.2016.12.016
18.
DeWaltD. A.GrossH. E.GipsonD. S.SelewskiD. T.DeWittE. M.DampierC. D.HindsP. S.HuangI.-C.ThissenD.VarniJ. W. (2015). PROMIS® pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions. Quality of Life Research, 24(9), 2195–2208. https://doi.org/10.1007/s11136-015-0953-3
19.
DonohoeC.SmithE. L. (2019). Psychological predictors of pain in children and adolescents with sickle cell disease: A scoping review. Journal of Pediatric Oncology Nursing, 36(2), 150–159. https://doi.org/10.1177/1043454218819457
20.
DyalB. W.EzenwaM. O.YoonS. L.FillingimR. B.YaoY.SchlaegerJ. M.SuarezM. L.WangZ. J.MolokieR. E.WilkieD. J. (2020). A QST-based pain phenotype in adults with sickle cell disease: Sensitivity and specificity of quality descriptors. Pain Practice, 20(2), 168–178. https://doi.org/10.1111/papr.12841
21.
EzenwaM. O.MolokieR. E.WangZ. J.YaoY.SuarezM. L.PullumC.SchlaegerJ. M.FillingimR. B.WilkieD.J. (2016). Safety and utility of quantitative sensory testing among adults with sickle cell disease: Indicators of neuropathic pain?Pain Practice, 16(3), 282–293. https://doi.org/10.1016/j.jpain.2016.12.016
22.
GuptaK.JahagirdarO.GuptaK. (2018). Targeting pain at its source in sickle cell disease. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 315(1), R104–R112. https://doi.org/10.1152/ajpregu.00021.2018
23.
HatzipantelisE. S.PanaZ. D.GombakisN.TaparkouA.TzimouliV.KletaD.AthanassiouM. (2013). Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease. International Journal of Hematology, 98(2), 158–163. https://doi.org/10.1007/s12185-013-1392-y
24.
HoppeC. C. (2014). Inflammatory mediators of endothelial injury in sickle cell disease. Hematology/Oncology Clinics of North America, 28(2), 265–286. https://doi.org/10.1016/j.hoc.2013.11.006
25.
JacobE.ChanV. W.HodgeC.ZeltzerL.ZurakowskiD.SethnaN. F. (2015). Sensory and thermal quantitative testing in children with sickle cell disease. Journal of Pediatric Hematology/Oncology, 37(3), 185–189. https://doi.org/10.1097/MPH.0000000000000214
26.
JeneretteC. M.BrewerC. A.EdwardsL. J.MishelM. H.GilK. M. (2014). An intervention to decrease stigma in young adults with sickle cell disease. Western Journal of Nursing Research, 36(5), 599–619. https://doi.org/10.1177/0193945913512724
KhanH.KrullM.HankinsJ. S.WangW. C.PorterJ. S. (2023). Sickle cell disease and social determinants of health: A scoping review. Pediatric Blood & Cancer, 70(2), Article e30089. https://doi.org/10.1002/pbc.30089
29.
KniselyM. R.TanabeP. J.WalkerJ. K. L.YangQ.ShahN. R. (2022). Severe persistent pain and inflammatory biomarkers in sickle cell disease: An exploratory study. Biological Research for Nursing, 24(1), 24–30. https://doi.org/10.1177/1099004211027220
30.
MillerR. E.BrownD. S.KeithS. W.HegartyS. E.SettyY.CampbellC. M.McCahanS. M.Gayen-BetalS.ByckH.StuartM. (2019). Quantitative sensory testing in children with sickle cell disease: Additional insights and future possibilities. British Journal of Haematology, 185(5), 925–934. https://doi.org/10.1111/bjh.15876
31.
MoodyK. L.MercerK.GlassM. (2019). An integrative review of the prevalence of depression among pediatric patients with sickle cell disease. Social Work in Public Health, 34(4), 343–352. https://doi.org/10.1080/19371918.2019.1606754
32.
O’LearyJ.CrawfordM. W.OdameI.ShortenG. D.McGrathP. A. (2014). Thermal pain and sensory processing in children with sickle cell disease. Clinical Journal of Pain, 30(3), 244–250. https://doi.org/10.1097/AJP.0b013e318292a38e
33.
PalermoT. M.LewandowskiA. S.LongA. C.BurantC. J. (2008). Validation of a self-report questionnaire version of the child activity limitations interview (CALI): The CALI-21. Pain, 139(3), 644–652. https://doi.org/10.1016/j.pain.2004.02.023
34.
PanepintoJ. A.TorresS.BendoC. B.McCavitT. L.DinuB.Sherman-BienS., Bemrich-Stolz, C., & Varni, J. W. (2013). PedsQL™ sickle cell disease module: Feasibility, reliability, and validity. Pediatr Blood Cancer, 60(8), 1338–1344. https://doi.org/10.1002/pbc.24491
35.
ReaderS. K.RockmanL. M.OkonakK. M.RuppeN. M.KeelerC. N.KazakA. E. (2020). Systematic review: Pain and emotional functioning in pediatric sickle cell disease. Journal of Clinical Psychology in Medical Settings, 27(2), 343–365. https://doi.org/10.1007/s10880-019-09647-x
36.
RolkeR.MagerlW.CampbellA.SchalberC.CaspariS.BirkleinF.TreedR. D. (2006). Quantitative sensory testing: A comprehensive protocol for clinical trials. European Journal of Pain, 10(1), 77–88. https://doi.org/10.1016/j.ejpain.2005.02.003
37.
RománM. E.HighlandJ.RetherfordD.PanA. Y.PanepintoJ. A.BrandowA. M. (2020). Neuropathic pain is associated with poor health-related quality of life in adolescents with sickle cell disease: A preliminary report. Pediatric Blood & Cancer, 67(12), Article e28698. https://doi.org/10.1002/pbc.28698
SilS.CohenL. L.BakshiN.WattA.HathawayM.AbudulaiF.DampierC. (2020). Changes in pain and psychosocial functioning and transition to chronic pain in pediatric sickle cell disease: A cohort follow-up study. The Clinical Journal of Pain, 36(6), 463–471. https://doi.org/10.1097/AJP.0000000000000827
40.
SilS.CohenL. L.DampierC. (2016). Psychosocial and functional outcomes in youth with chronic sickle cell pain. Clinical Journal of Pain, 32(6), 527–533. https://doi.org/10.1097/AJP.0000000000000289
41.
SilS.CohenL. L.DampierC. (2019). Pediatric pain screening identifies youth at risk of chronic pain in sickle cell disease. Pediatric Blood & Cancer, 66(3), Article e27538. https://doi.org/10.1002/pbc.27538
42.
SilS.ManikowskiA.SchneiderM.CohenL. L.DampierC. (2022). Identifying chronic pain subgroups in pediatric sickle cell disease: A cluster-analytic approach. The Clinical Journal of Pain, 38(10), 601–611. https://doi.org/10.1097/AJP.0000000000001065
43.
StarkweatherA. R.HeinemanA.StoreyS.RubiaG.LyonD.GreenspanJ.DorseyS. G. (2015). Methods to measure peripheral and central sensitization using quantitative sensory testing: A focus on individuals with low back pain. Applied Nursing Research, 29(2016), 237–241. https://doi.org/10.1016/j.apnr.2015.03.0130897-1897
44.
VincentL.VangD.NguyenJ.GuptaM.LukK.EricsonM. E.SimoneD. A.GuptaK. (2013). Mast cell activation contributes to sickle cell pathobiology and pain in mice. Blood, 122(11), 1853–1862. https://doi.org/10.1182/blood-2013-04-498105
45.
Vistica-SampinoE.ReaR.CarterB.BoruchovD.ZempskyW. (2020, September 23–25). Chronic pain in children and adolescents with sickle cell disease [Poster Abstract]. 2020 Sickle Cell Disease Research and Educational Symposium. Virtual Conference.
46.
WakefieldE. O.PoppJ. M.DaleL. P.SantanelliJ. P.PantaleaoA.ZempskyW. T. (2017). Perceived racial bias and health-related stigma among youth with sickle cell disease. Journal of Developmental and Behavioral Pediatrics, 38(2), 129–134. https://doi.org/10.1097/DBP.0000000000000381
47.
WilkieD. J.MolokieR.Boyd-SealD.SuarezM. L.KimY. O.ZongS., Wittert, H., Zhao, Z., Saunthararajah, Y., & Wang, Z. J. (2010). Patient-reported outcomes: Descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease. Journal of the National Medical Association, 102(1), 18–21. https://doi.org/10.1016/s0027-9684(15)30471-5
ZempskyW. T.O’HaraE. A.SantanelliJ. P.PalermoT. M.NewT.Smith-WhitleyK.CasellaJ. F. (2013). Validation of the sickle cell disease pain burden interview–youth. The Journal of Pain, 14(9), 975–982. https://doi.org/10.1016/j.jpain.2013.03.007
51.
ZempskyW. T.WakefieldE. O.SantanelliJ. P.NewT.Smith-WhitleyK.CasellaJ. F.PalermoT. M. (2017). Widespread pain among youth with sickle cell disease hospitalized with vasoocclusive pain: A different clinical phenotype?The Clinical Journal of Pain, 33(4), 335–339. https://doi.org/10.1097/AJP.0000000000000403
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
